Skip to content

Use of AI Chatbots for Mental Health

Use of AI Chatbots for Mental Health - an Online Survey of Patients With Severe Mental Illness

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07658547
Acronym
NUKI-PSY
Enrollment
150
Registered
2026-06-22
Start date
2026-06-01
Completion date
2026-11-01
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Mental Illness

Brief summary

The goal of this observational study is to learn how patients with mental disorders use, perceive, and evaluate generative artificial intelligence (AI) chatbots for mental health-related purposes. The study aims to investigate usage patterns, expectations, experiences, perceived benefits, barriers, and concerns regarding AI chatbots among adults receiving psychiatric or psychotherapeutic treatment. The main questions it aims to answer are: * "How do patients with mental disorders use generative AI chatbots in the context of their mental health?" * "What expectations, attitudes, and experiences do patients have regarding AI chatbots for mental health support?" Participants will: * Provide electronic informed consent before participation. * Complete a one-time anonymous online survey lasting approximately 8 to 10 minutes. * Answer questions about sociodemographic characteristics, psychiatric diagnoses, psychological distress, and digital device use. * Report their expectations regarding AI chatbots for mental health support. * Provide information about AI chatbot use, including frequency, duration, applications used, and purposes of use. * Answer questions regarding satisfaction, trust, privacy concerns, perceived problems, and potential future integration of AI chatbots into mental health care. * Optionally provide qualitative comments and suggestions in open-text fields. There is no intervention, randomization, control group, or comparison arm in this study. The study follows a prospective cross-sectional mixed-methods design using quantitative survey data and qualitative free-text responses.

Interventions

None listed

Sponsors

Medizinische Hochschule Brandenburg Theodor Fontane
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* diagnosed mental illness

Exclusion criteria

* incapable of giving consent

Design outcomes

Primary

MeasureTime frame
Percentage of patients who have used generative AI for mental health issuesup to 6 months

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORSchwarz

Medizinische Hochschule Brandenburg Theodor Fontane

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026